In situ detection of superoxide anion. Hydroethidine (Molecular Probes, Eugene, OR), an oxidative fluorescent dye, was used to evaluate levels of superoxide anion in situ as previously described (2, 3) . The numbers of ethidium bromide fluorescence-positive endothelial cells or smooth muscle cells were counted at a screen magnification of × 400 in 6 or 8 different regions. Values were expressed per high-power field.
TUNEL assay.
The terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay was performed by using the ApopTag® Fluorescein In Situ Apoptosis Detection Kit (S7160, Chemicon) as previously described (2). The numbers of apoptotic cells in endothelial cells or smooth muscle cells were counted at a screen magnification of × 400 in 6 or 8 different regions. Values were expressed per high-power field.
Western blot.
The collected penile tissues were immediately stored within liquid nitrogen. The tissues were then homogenized with small volume of liquid nitrogen. This experimental step was repeated several times till changing to the complete powder of tissues. And then, the Ripa buffer (200 μl, a protease inhibitor cocktail, Sigma-Aldrich) was added into the homogenates, and transferred to 1.5 ml eppendorf tubes. After incubating on ice for 20 min, the homogenates were centrifuged at 13,000 g for 10 min at 4°C and the concentrations of each protein in the supernatants were measured using the Universal Microplate Reader ELx800G (BioTek Instruments Inc., Winooski, VT). Equal amounts of protein (100 μg per lane) were electrophoresed on sodium dodecylsulfate-polyacrylamide gels (6% to 10%), transferred to nitrocellulose membranes, and probed with antibodies to FLAG M1 (Sigma-Aldrich; 1:400), eNOS (Transduction Laboratories, Inc., Lexington, KY; 1:300), phospho-eNOS (Ser1177, Cell Signaling; 1:300), p47 phox (an active catalytic subunit of NADPH oxidase, Santa Cruz Biotechnology, Santa Cruz, CA; 1:500), inducible NOS (iNOS, Abcam, Cambridge, U.K.; 1:300), vascular endothelial (VE)cadherin (Santa Cruz Biotechnology; 1:300), zonula occludens-1 (ZO-1, Zymed Laboratories, South San Francisco, CA; 1:300), occludin (Zymed Laboratories; 1:300), claudin-5 (Zymed Laboratories; 1:300), or β-actin (Abcam). The results were quantified by densitometry (n = 4 or 6 per group).
cGMP determinations.
At 2 weeks after intracavernous COMP-Ang1 protein injection (n = 4 per group), the corpus cavernosum tissue was removed and rinsed with PBS, quick frozen in liquid nitrogen, and stored at -70°C until cGMP determination. The samples were then processed according to the instructions provided with the kit (Cayman Chemical, Ann Arbor, MI). Data are expressed as pmol/mg of wet weight tissue.
Measurement of plasma nitrite/nitrate (NO x ) levels.
Production of nitric oxide (NO) in the plasma was evaluated by measuring nitrite/nitrate (NO x ) levels using a commercially available colorimetric assay kit (Cayman Chemical). Blood was extracted by direct cardiac puncture and was collected in chilled EDTA containers and centrifuged, and plasma was stored at -80 o C until analysis. Plasma was filtered through a 10-kDa molecular weight cut-off filter (Millipore Co., Bedford, MA) at 12,000 g for 20 min, and incubated with nitrate reductase for 3 h to convert nitrate to nitrite. After incubation, Griess reagents were added to the plasma and total NO x levels were measured spectrophotometrically at 540 nm (Universal Microplate Reader ELx800G, Bio-Tek Instruments Inc., Highland Park, VT).
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Cheng G, Thompson RP, Gourdie RG. Improved detection reliability of beta-galactosidase in histological preparations. Figure 1 . In vivo COMP-Ang1 or β-gal expression in diabetic corpus cavernosum tissue. A: Western blot analysis of the expression of COMP-Ang1 protein with anti-FLAG M1 antibody in cavernous tissues from diabetic mice 1, 6, and 24 h and 3, 7, 14, and 21 days after intracavernous injection of ad-COMP-Ang1 (left, 2 × 10 8 parts/20 μl) or COMP-Ang1 protein (right, 5.8 μg/20 μl). The relative ratio of COMP-Ang1 to β-actin measured 3 days after injection of ad-COMP-Ang1 or 1 h after injection of COMP-Ang1 protein was arbitrarily set equivalent to 1. Bars represent the mean ± SE of four independent experiments. B: Anti-FLAG staining of cavernous tissue from diabetic mice 7 days after intracavernous injection of ad-LacZ (2 × 10 8 parts/20 μl) or ad-COMP-Ang1 (2 × 10 8 parts/20 μl) and 1 h after intracavernous injection of PBS (20 μl) or COMP-Ang1 protein (5.8 μg/20 μl). Arrows denote positive endothelial cells. 2 nd Ab, secondary antibody control. Scale bar = 50 μm. C: Localization of β-gal in the whole penis from diabetic mice 7 days after administration of virus vehicle alone or of ad-LacZ (2 × 10 8 parts/20 μl). Arrows denote positive endothelial cells. Tissue was counterstained nuclear fast red. Scale bar = 50 μm. GP, glans penis (corpus spongiosum); PS, penile shaft (corpus cavernosum). Figure 2 . Adenoviral COMP-Ang1 gene or COMP-Ang1 protein transfer restores intracavernous pressure (ICP) elicited by electrical stimulation of the cavernous nerve. A: Representative ICP responses for age-matched control (C), untreated diabetic mice (N) or diabetic mice stimulated at 4 weeks after intracavernous injection of ad-LacZ (L, 2 × 10 8 parts/20 μl), PBS (P, 20 μl), ad-COMP-Ang1 (CA, 2 × 10 8 parts/20 μl), or COMP-Ang1 protein (CP, 5.8 μg/20 μl). A single injection of ad-LacZ or ad-COMP-Ang1 (day 0) and repeated injections of PBS or COMP-Ang1 protein (days -3 and 0) were done into the mid portion of the corpus cavernosum. Cavernous nerve was stimulated at 1 V and 5 V. The stimulus interval is indicated by a solid bar. B, C: Ratios of mean maximal ICP and total ICP (area under the curve) to mean systolic blood pressure (MSBP) were calculated for each group. Each bar depicts the mean ± SE from n = 6 animals per group. *P < 0.01 vs. C, CA, and CP groups, #P < 0.01 vs. N, L, and P groups, †P < 0.05 vs. C group. STZ, streptozotocin; DM, diabetes mellitus. Figure 3 . Intracavernous pressure (ICP) elicited by electrical stimulation of the cavernous nerve returns to baseline levels 6 and 8 weeks after administration of adenoviral COMP-Ang1 gene or COMP-Ang1 protein. A: Representative ICP responses for age-matched control (C) or diabetic mice stimulated at 6 weeks after intracavernous injection of PBS (P, 20 μl), ad-COMP-Ang1 (CA, 2 × 10 8 parts/20 μl), or COMP-Ang1 protein (CP, 5.8 μg/20 μl). A single injection of ad-COMP-Ang1 (day 0) and repeated injections of PBS or COMP-Ang1 protein (days -3 and 0) were done into the mid portion of the corpus cavernosum. Cavernous nerve was stimulated at 5 V. The stimulus interval is indicated by a solid bar. B, C: Ratios of mean maximal ICP and total ICP (area under the curve) to mean systolic blood pressure (MSBP) were calculated for each group. Each bar depicts the mean ± SE from n = 4 animals per group. *P < 0.01 vs. C group. D: Representative ICP responses for each group of mice stimulated at 8 weeks after treatment. E, F: Ratios of mean maximal ICP and total ICP (area under the curve) to mean systolic blood pressure (MSBP) were calculated for each group. Each bar depicts the mean ± SE from n = 4 animals per group. *P < 0.01 vs. C group. STZ, streptozotocin; DM, diabetes mellitus. Figure 4 . COMP-Ang1 protein transfer decreases p47 phox and iNOS expression in the corpus cavernosum tissue. A: Representative Western blot for p47 phox and iNOS in age-matched control (C), untreated diabetic mice (N), or diabetic mice 2 weeks after receiving intracavernous injection of PBS (P, days -3 and 0; 20 μl) or COMP-Ang1 protein (CP, days -3 and 0; 5.8 μg/20 μl). B, C: Data are presented as the relative density of each protein compared with that of β-actin. The relative ratio of the control group was arbitrarily set equivalent to 1. Data are representative of six independent experiments. *P < 0.05 vs. C and CP groups, #P < 0.05 vs. N and P groups. iNOS, inducible nitric oxide synthase; DM, diabetes mellitus. 
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